Klaas van der Spek1, Raymond T C M Koopmans1,2, Martin Smalbrugge3, Marjorie H J M G Nelissen-Vrancken4, Roland B Wetzels1, Claudia H W Smeets1, Erica de Vries1, Steven Teerenstra5, Sytse U Zuidema6, Debby L Gerritsen1,7. 1. Department of Primary and Community Care, Centre for Family Medicine, Geriatric Care and Public Health, Radboud University Medical Centre, Nijmegen Huispost 117 ELG, PO Box 9101, 6500 HB Nijmegen, The Netherlands. 2. Joachim and Anna, Centre for Specialized Geriatric care, Nijmegen, Radboudumc Alzheimer Centrum, Nijmegen. 3. Department of General Practice and Elderly Care Medicine/EMGO+ Institute for Health and Care Research, VU Medical Centre, PO Box 7057, 1007 MB Amsterdam, The Netherlands. 4. Dutch Institute for Rational Use of Medicine, PO Box 3089, 3502 GB Utrecht, The Netherlands. 5. Department for Health Evidence, Group Biostatistics, Radboud Institute of Health Sciences, Radboud University Medical Centre, Nijmegen Huispost 133 HEV, PO Box 9101, 6500 HB Nijmegen, The Netherlands. 6. Department of General Practice and Elderly Care Medicine, University of Groningen, University Medical Centre Groningen, HPC FA21, PO Box 196, 9700 AD Groningen. 7. Radboudumc Alzheimer Centrum, Nijmegen.
Abstract
Objective: We studied the efficacy of biannual structured medication reviews to improve the appropriateness of psychotropic drug (PD) prescriptions for neuropsychiatric symptoms (NPS) in nursing home patients with dementia. Study Design and Setting: In this randomised controlled trial, the intervention encompassed a structured multidisciplinary medication review by physician, pharmacist and nurse. During this 18-month study, the patient's medical files were assessed every 6 months. The primary outcome was the appropriateness of PD prescriptions defined by the Appropriate Psychotropic drug use In Dementia (APID) index sum score, lower scores indicating more appropriate use. Results: At baseline, 380 patients were included, of which 222 were randomised to the intervention group. Compared to the control group, the APID index sum score in the intervention group improved significantly for all PD prescriptions (-5.28, P = 0.005). Conclusion: We advise the implementation of a structured, repeated medication review with the essential roles of pharmacist, physician and nurse, into daily practice. This work was supported and funded by the Netherlands Organisation for Health Research and Development (ZonMw). Netherlands Trial Register (NTR3569).
RCT Entities:
Objective: We studied the efficacy of biannual structured medication reviews to improve the appropriateness of psychotropic drug (PD) prescriptions for neuropsychiatric symptoms (NPS) in nursing home patients with dementia. Study Design and Setting: In this randomised controlled trial, the intervention encompassed a structured multidisciplinary medication review by physician, pharmacist and nurse. During this 18-month study, the patient's medical files were assessed every 6 months. The primary outcome was the appropriateness of PD prescriptions defined by the Appropriate Psychotropic drug use In Dementia (APID) index sum score, lower scores indicating more appropriate use. Results: At baseline, 380 patients were included, of which 222 were randomised to the intervention group. Compared to the control group, the APID index sum score in the intervention group improved significantly for all PD prescriptions (-5.28, P = 0.005). Conclusion: We advise the implementation of a structured, repeated medication review with the essential roles of pharmacist, physician and nurse, into daily practice. This work was supported and funded by the Netherlands Organisation for Health Research and Development (ZonMw). Netherlands Trial Register (NTR3569).
Authors: Amy Werremeyer; Jolene Bostwick; Carla Cobb; Tera D Moore; Susie H Park; Cristofer Price; Jerry McKee Journal: Ment Health Clin Date: 2020-11-05
Authors: Claudia M Groot Kormelinck; Charlotte F van Teunenbroek; Boudewijn J Kollen; Margreet Reitsma; Debby L Gerritsen; Martin Smalbrugge; Sytse U Zuidema Journal: BMC Psychiatry Date: 2019-10-12 Impact factor: 3.630
Authors: Ans J M J Mulders; Sytse U Zuidema; Renée Leeuwis; Hans Bor; Frans R J Verhey; Raymond T C M Koopmans Journal: Int J Geriatr Psychiatry Date: 2019-04-29 Impact factor: 3.485
Authors: Aisling A Jennings; Tony Foley; Kieran A Walsh; Alice Coffey; John P Browne; Colin P Bradley Journal: Int J Geriatr Psychiatry Date: 2018-06-13 Impact factor: 3.485